Page last updated: 2024-11-05

tosufloxacin and Tuberculosis, Pulmonary

tosufloxacin has been researched along with Tuberculosis, Pulmonary in 1 studies

tosufloxacin: quinolone anti-infective agent; structure given in first source
tosufloxacin : A racemate comprising equimolar amounts of (R)- and (S)-tosufloxacin.
7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid : A 1,8-naphthyridine derivative that is 4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid bearing additional 2,4-difluorophenyl, fluoro and 3-aminopyrrolidin-1-yl substituents at positions 1, 6 and 7 respectively.

Tuberculosis, Pulmonary: MYCOBACTERIUM infections of the lung.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujishima, N1
Komiya, K1
Matsunaga, N1
Usagawa, Y1
Yamasue, M1
Hashinaga, K1
Umeki, K1
Nureki, SI1
Ando, M1
Matsunaga, T1
Kadota, JI1

Other Studies

1 other study available for tosufloxacin and Tuberculosis, Pulmonary

ArticleYear
A Pitfall of Treatment with Tosufloxacin for Pneumonia That Might Be Lung Tuberculosis.
    Internal medicine (Tokyo, Japan), 2019, Volume: 58, Issue:2

    Topics: Aged, 80 and over; Diagnosis, Differential; Fluoroquinolones; Humans; Male; Mycobacterium tuberculos

2019